Cargando…
Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia—The State-of-the-Art Knowledge and Future Prospects
Acute lymphoblastic leukemia (ALL) is the most common malignancy among children. Despite the enormous progress in ALL therapy, resulting in achieving a 5-year survival rate of up to 90%, the ambitious goal of reaching a 100% survival rate is still being pursued. A typical ALL treatment includes thre...
Autores principales: | Kośmider, Kamil, Karska, Katarzyna, Kozakiewicz, Agata, Lejman, Monika, Zawitkowska, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999045/ https://www.ncbi.nlm.nih.gov/pubmed/35409154 http://dx.doi.org/10.3390/ijms23073795 |
Ejemplares similares
-
Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
por: Malczewska, Marta, et al.
Publicado: (2022) -
Genetic Disorders with Predisposition to Paediatric Haematopoietic Malignancies—A Review
por: Filipiuk, Aleksandra, et al.
Publicado: (2022) -
Severe complications in the induction phase of therapy in a pediatric patient with T-cell acute lymphoblastic leukemia: A case report
por: Rocka, Agata, et al.
Publicado: (2023) -
Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms
por: Lejman, Monika, et al.
Publicado: (2021) -
Hypodiploidy in a pediatric patient of T-cell acute lymphoblastic leukemia: a case report
por: Stefaniak, Martyna, et al.
Publicado: (2021)